| Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism W Arlt, K Lang, AJ Sitch, AS Dietz, Y Rhayem, I Bancos, A Feuchtinger, ... JCI insight 2 (8), 2017 | 239 | 2017 |
| Effectiveness of metyrapone in treating Cushing's syndrome: a retrospective multicenter study in 195 patients E Daniel, S Aylwin, O Mustafa, S Ball, A Munir, K Boelaert, V Chortis, ... The Journal of Clinical Endocrinology & Metabolism 100 (11), 4146-4154, 2015 | 214 | 2015 |
| Management of endocrine disease: imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis J Dinnes, I Bancos, L Ferrante di Ruffano, V Chortis, C Davenport, ... European journal of endocrinology 175 (2), R51-R64, 2016 | 200 | 2016 |
| Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement V Chortis, AE Taylor, P Schneider, JW Tomlinson, BA Hughes, DM O'Neil, ... The Journal of Clinical Endocrinology & Metabolism 98 (1), 161-171, 2013 | 162 | 2013 |
| Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study I Bancos, AE Taylor, V Chortis, AJ Sitch, C Jenkinson, CJ Davidge-Pitts, ... The lancet Diabetes & endocrinology 8 (9), 773-781, 2020 | 161 | 2020 |
| CT characteristics of pheochromocytoma: relevance for the evaluation of adrenal incidentaloma L Canu, JAW Van Hemert, MN Kerstens, RP Hartman, A Khanna, ... The Journal of Clinical Endocrinology & Metabolism 104 (2), 312-318, 2019 | 141 | 2019 |
| Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality I Bancos, J Hazeldine, V Chortis, P Hampson, AE Taylor, JM Lord, W Arlt European journal of endocrinology 176 (4), 471-480, 2017 | 123 | 2017 |
| Therapy of endocrine disease: improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic … I Bancos, F Alahdab, RK Crowley, V Chortis, DA Delivanis, D Erickson, ... European journal of endocrinology 175 (6), R283-R295, 2016 | 120 | 2016 |
| Steroid metabolome analysis in disorders of adrenal steroid biosynthesis and metabolism KH Storbeck, L Schiffer, ES Baranowski, V Chortis, A Prete, L Barnard, ... Endocrine reviews 40 (6), 1605-1625, 2019 | 117 | 2019 |
| Cardiometabolic disease burden and steroid excretion in benign adrenal tumors: a cross-sectional multicenter study A Prete, A Subramanian, I Bancos, V Chortis, S Tsagarakis, K Lang, ... Annals of internal medicine 175 (3), 325-334, 2022 | 80 | 2022 |
| Urine steroid metabolomics as a novel tool for detection of recurrent adrenocortical carcinoma V Chortis, I Bancos, T Nijman, LC Gilligan, AE Taylor, CL Ronchi, ... The Journal of Clinical Endocrinology & Metabolism 105 (3), e307-e318, 2020 | 54 | 2020 |
| NNT is a key regulator of adrenal redox homeostasis and steroidogenesis in male mice E Meimaridou, M Goldsworthy, V Chortis, E Fragouli, PA Foster, W Arlt, ... Journal of Endocrinology 236 (1), 13-28, 2018 | 51 | 2018 |
| Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysis I Bancos, F Alahdab, RK Crowley, V Chortis, DA Delivanis, D Erickson, ... European journal of endocrinology 175 (6), R283-R295, 2016 | 39 | 2016 |
| Human fetal adrenal cells retain age‐related stem‐and endocrine‐differentiation potential in culture G Poli, E Sarchielli, D Guasti, S Benvenuti, L Ballerini, B Mazzanti, ... The FASEB Journal 33 (2), 2263-2277, 2019 | 38 | 2019 |
| Effects of germline CYP2W1* 6 and CYP2B6* 6 single nucleotide polymorphisms on mitotane treatment in adrenocortical carcinoma: a multicenter ENSAT study B Altieri, S Sbiera, S Herterich, S De Francia, S Della Casa, A Calabrese, ... Cancers 12 (2), 359, 2020 | 31 | 2020 |
| Nicotinamide nucleotide transhydrogenase as a novel treatment target in adrenocortical carcinoma V Chortis, AE Taylor, CL Doig, MD Walsh, E Meimaridou, C Jenkinson, ... Endocrinology 159 (8), 2836-2849, 2018 | 31 | 2018 |
| Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort study F Majidi, S Martino, M Kondakci, C Antke, M Haase, V Chortis, W Arlt, ... European journal of endocrinology 183 (4), 453-462, 2020 | 23 | 2020 |
| Supine or sitting? Economic considerations regarding patient position during plasma metanephrine analysis for the exclusion of chromaffin tumours. V Chortis, I Bancos, RK Crowley, W Arlt Clinical endocrinology 82 (3), 2015 | 22 | 2015 |
| Bilateral testicular tumors resulting in recurrent Cushing disease after bilateral adrenalectomy T Puar, M Engels, AE van Herwaarden, FCGJ Sweep, ... The Journal of Clinical Endocrinology & Metabolism 102 (2), 339-344, 2017 | 19 | 2017 |
| Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and … M Terzolo, M Fassnacht, P Perotti, R Libé, D Kastelan, A Lacroix, W Arlt, ... The Lancet Diabetes & Endocrinology 11 (10), 720-730, 2023 | 15 | 2023 |
